- Home
- WASH vs AUTL Comparison
WASH vs AUTL Comparison
Compare WASH & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- AUTL
- Stock Information
- Founded
- WASH 1800
- AUTL 2014
- Country
- WASH United States
- AUTL United Kingdom
- Employees
- WASH N/A
- AUTL N/A
- Industry
- WASH Major Banks
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WASH Finance
- AUTL Health Care
- Exchange
- WASH Nasdaq
- AUTL Nasdaq
- Market Cap
- WASH 613.2M
- AUTL 590.8M
- IPO Year
- WASH N/A
- AUTL 2018
- Fundamental
- Price
- WASH $32.47
- AUTL $2.37
- Analyst Decision
- WASH Hold
- AUTL Strong Buy
- Analyst Count
- WASH 2
- AUTL 3
- Target Price
- WASH $34.00
- AUTL $10.20
- AVG Volume (30 Days)
- WASH 186.7K
- AUTL 1.2M
- Earning Date
- WASH 01-29-2025
- AUTL 03-13-2025
- Dividend Yield
- WASH 6.90%
- AUTL N/A
- EPS Growth
- WASH N/A
- AUTL N/A
- EPS
- WASH 2.67
- AUTL N/A
- Revenue
- WASH $188,967,000.00
- AUTL $10,091,000.00
- Revenue This Year
- WASH N/A
- AUTL $851.83
- Revenue Next Year
- WASH $11.60
- AUTL $264.18
- P/E Ratio
- WASH $12.16
- AUTL N/A
- Revenue Growth
- WASH N/A
- AUTL 82.71
- 52 Week Low
- WASH $24.11
- AUTL $2.07
- 52 Week High
- WASH $40.59
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- WASH 50.61
- AUTL 46.88
- Support Level
- WASH $31.99
- AUTL $2.12
- Resistance Level
- WASH $33.39
- AUTL $2.38
- Average True Range (ATR)
- WASH 0.94
- AUTL 0.13
- MACD
- WASH 0.37
- AUTL 0.02
- Stochastic Oscillator
- WASH 79.78
- AUTL 37.23
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.